
GC37533
RIP1 kinase inhibitor 1
Also known as (3S)-3-(2-benzyl-3-chloro-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepine-8-carbonitrile
RIP1 kinase inhibitor 1 (compound 22) is a highly potent, orally available, and brain-penetrating RIP1 kinase inhibitor (pKi=9·04)
ChemicalCAS2095515-38-9MW461.9FormulaC24H20ClN5O3
- CAS number
- 2095515-38-9
- Molecular weight
- 461.9
- Formula
- C24H20ClN5O3
- Solubility
- Soluble in DMSO
- InChIKey
- JWKONLKXWPCOJF-IBGZPJMESA-N
- Catalogue number
- GC37533
- Brand
- GLPBIO
Computed properties PubChem CID 132471860 · XLogP 3.2 · TPSA 91.5 Ų · H-bond donors 0
- XLogP
- 3.2
- TPSA
- 91.5 Ų
- H-bond donors
- 0
- H-bond acceptors
- 5
- Rotatable bonds
- 3
- Heavy atoms
- 33
SMILES CN1C2=C(C=C(C=C2)C#N)OC[C@@H](C1=O)N3CCC4=C(N(N=C4C3=O)CC5=CC=CC=C5)Cl
Computed descriptors from PubChem (CID 132471860), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il